AU2001284287A1 - Pharmaceutical combination containing salmeterol and fluticasone - Google Patents

Pharmaceutical combination containing salmeterol and fluticasone

Info

Publication number
AU2001284287A1
AU2001284287A1 AU2001284287A AU8428701A AU2001284287A1 AU 2001284287 A1 AU2001284287 A1 AU 2001284287A1 AU 2001284287 A AU2001284287 A AU 2001284287A AU 8428701 A AU8428701 A AU 8428701A AU 2001284287 A1 AU2001284287 A1 AU 2001284287A1
Authority
AU
Australia
Prior art keywords
fluticasone
pharmaceutical combination
combination containing
containing salmeterol
salmeterol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001284287A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of AU2001284287A1 publication Critical patent/AU2001284287A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
AU2001284287A 2000-09-07 2001-09-06 Pharmaceutical combination containing salmeterol and fluticasone Abandoned AU2001284287A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0021927.9 2000-09-07
GBGB0021927.9A GB0021927D0 (en) 2000-09-07 2000-09-07 Use of pharmaceutical combination
PCT/GB2001/004001 WO2002019995A2 (en) 2000-09-07 2001-09-06 Pharmaceutical combination containing salmeterol and fluticasone

Publications (1)

Publication Number Publication Date
AU2001284287A1 true AU2001284287A1 (en) 2002-03-22

Family

ID=9899002

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001284287A Abandoned AU2001284287A1 (en) 2000-09-07 2001-09-06 Pharmaceutical combination containing salmeterol and fluticasone

Country Status (3)

Country Link
AU (1) AU2001284287A1 (en)
GB (1) GB0021927D0 (en)
WO (1) WO2002019995A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0124523D0 (en) * 2001-10-12 2001-12-05 Glaxo Group Ltd Pharmaceutical combination

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0416925A3 (en) * 1989-09-07 1991-09-25 Glaxo Group Limited Use of 4-hydroxy-alpha 1-(((6-(4-phenylbutoxy)hexyl)amino)methyl)-1,3-benzenedimethanol or its salts in the treatment of allergy and inflammation
WO1997046243A1 (en) * 1996-06-04 1997-12-11 The Procter & Gamble Company A nasal spray containing an intranasal steroid and an antihistamine
GB9622173D0 (en) * 1996-10-24 1996-12-18 Glaxo Group Ltd Particulate Products
GB9924992D0 (en) * 1999-10-21 1999-12-22 Glaxo Group Ltd Pharmaceutical aerosol formulations
AU2206801A (en) * 1999-12-24 2001-07-09 Alan Leslie Cripps Pharmaceutical aerosol formulation of salmeterol and fluticasone propionate

Also Published As

Publication number Publication date
WO2002019995A2 (en) 2002-03-14
GB0021927D0 (en) 2000-10-25
WO2002019995A3 (en) 2002-08-22

Similar Documents

Publication Publication Date Title
HK1040995A1 (en) 2-oxoquinoline compounds and medicinal uses thereof
AU2001290257A2 (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
AU2001290257A1 (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
ZA200110022B (en) Thiazoloderivatives and pharmaceutical compositions containing them.
IL152451A0 (en) 2-chloro-2-nitrophenylcarboxamide derivatives and pharmaceutical compositions containing the same
HUP0301178A3 (en) Glucopyranosyloxybenzylbenzene derivatives and pharmaceutical compositions containing the same
IL153123A0 (en) N-ureidoheterocycloalkyl-piperidine derivatives and pharmaceutical compositions containing the same
AU2002306269A1 (en) N-arylphenylacetamide derivatives and pharmaceutical composition containing the same
IL177018A0 (en) Cyclopropyl-fused pyrrolidine derivatives and pharmaceutical compositions containing the same
IL146230A0 (en) 3α-HYDROXY-3β-METHOXYMETHYL-SUBSTITUTED STEROIDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
AU4672301A (en) Medical combinations comprising formoterol and fluticasone proprionate
IL150383A0 (en) Glyburide and pharmaceutical compositions containing the same
AU2001269474A1 (en) Phenylpyridazine Compounds and Medicines Containing the Same
HUP0300334A3 (en) Pharmaceutical preparations and their manufacture
AU2002218502A1 (en) Lactam compounds and medicinal use thereof
HUP0200055A3 (en) 16-hydroxyestrienes and pharmaceutical compositions containing the same
MXPA03001752A (en) Pharmaceutical formulation of salmeterol and fluticasone propionate.
HK1064042A1 (en) Medicines and medicinal kits
AU2001227084A1 (en) N-arylhydrazide compounds and use thereof as drugs
AU2002237400A1 (en) Pharmaceutical formulation comprising r-salmeterol and fluticasone propionate
AU4853801A (en) Medical combination comprising salmeterol and budesonide
AU4853601A (en) Medical combinations comprising mometasone and salmeterol
AU4854101A (en) Medical combinations comprising formoterol and mometasone
AU2001232244A1 (en) Drug comprising combination
AU2001274535A1 (en) Hydroxyformamidine derivatives and medicines containing the same